|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.010 USD | -5.11% |
|
-9.42% | -30.65% |
| 12-12 | Weight-loss drug developers line up to tap lucrative market as competition heats up | RE |
| 12-08 | Weight-loss drug developers line up to tap lucrative market as competition heats up | RE |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Neutral | Neutral |
| Resistance | 5.61 | 7.71 | 7.03 |
| Spread/Res. | -10.87% | -35.15% | -28.88% |
| Spread/Supp. | +5.04% | +47.93% | +44.93% |
| Support | 4.76 | 3.38 | 3.45 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Equities
- ALT Stock
- Charts Altimmune, Inc.
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition